Saturday 17 October 2026
Export MGTX’s income statement to Excel — free account
MeiraGTx Holdings PLC
MGTX Healthcare Biotechnology
MeiraGTx Holdings PLC’s revenue for fiscal 2025 (year ended December 2025) was $81.4 million, up 144.6% from fiscal 2024. In the quarter to June 2026, revenue grew 8,608.6%, EPS grew 466.7%, free cash flow grew 13.1% and total debt rose 28.6%, each against the same quarter a year earlier.
9.28
0.61
−6.17%
Follow MGTX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(611.42%) | (368.19%) | 963.07% | 72.22% | |
Piotroski F-Score |
4 | 5 | 6 | 6 | |
| (69.00%) | (44.42%) | (51.44%) | 26.54% | ||
ROIC |
0.00% | 0.00% | 0.00% | 66.60% | |
Return on Tangible Assets |
1,520.40% | (152.94%) | (532.23%) | 30.31% | |
Average Days of Receivables |
157.23 | 82.00 | 82.19 | 40.64 | |
Free Cash Flow per Share |
(1.49) | (0.62) | 0.05 | 0.11 | |
Free Cash Flow |
(120.50) | (50.06) | 4.28 | 10.12 | |
Capital Expenditures |
(4.24) | (3.70) | (3.99) | (3.57) | |
| Other line items | |||||
Cash ROIC |
849.50% | (45.53%) | 6.78% | 2.21% | |
Accounts Receivable Turnover |
2.71 | 5.82 | 6.96 | 15.57 | |
Accounts Payable Turnover |
0.63 | 0.29 | 0.20 | 0.44 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
486.06 | 758.64 | 1,659.89 | 522.49 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | (0.03) | |
Research and Development Expense of Revenue |
447.87% | 159.25% | 161.52% | 38.53% | |
Selling, General and Administrative Expense of Revenue |
191.06% | 64.99% | 65.78% | 13.12% | |
Share Based Compensation of Revenue |
82.51% | 27.16% | 26.17% | 4.78% | |
Interest Coverage |
(13.06) | (8.69) | (8.76) | 14.75 | |
Operating CF/Net income |
0.69 | 0.41 | (0.07) | 0.17 | |
Depreciation/Fixed assets |
0.13 | 0.13 | 0.13 | 0.13 | |
Capex/Depreciation |
(0.31) | (0.27) | (0.29) | (0.26) | |
Revenue per Share |
0.34 | 1.01 | 0.98 | 4.35 | |
Operating CF per Share |
(1.44) | (0.58) | 0.10 | 0.15 | |
Capex per Share |
(0.05) | (0.05) | (0.05) | (0.04) | |
Capex to Sales |
0.15 | 0.05 | 0.05 | 0.01 |
Columns are period end dates